Skip to content
Screener

Orthofix Medical Inc. OFIX Q2 2026 earnings

Reported August 5, 2026 · Before market open

Revenue$210.9MBeat by $1.7M
EPS-$0.39Beat by $0.02
Revenue estimate$209.3M
EPS estimate-$0.41
“Our second quarter results provide further evidence that the operational actions we have taken over the past year are beginning to show up more clearly in the business. We delivered 5% pro forma, constant-currency net sales growth, supported by double-digit growth in Global Limb Reconstruction and Spine Fixation, sequential momentum in Biologics, and the restoration of Medicare reimbursement for bone growth stimulators, which removes a meaningful headwind for our Therapeutic Solutions business as we enter the second half of the year.”
Massimo Calafiore

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$210.7M
EPS estimate$0.11

Financials

Q2 2026

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M—

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$370.26M-38.6%
Enterprise value$504.13M-29.4%
P/S0.4×-0.3×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Segments

By segment

See full
Global Spine$173.2M+2.0%
Global Limb Reconstruction$37.7M—

FAQ

When did Orthofix Medical Inc. report Q2 2026 earnings?
Orthofix Medical Inc. (OFIX) reported Q2 2026 earnings on August 5, 2026 before market open.
What were Orthofix Medical Inc.'s Q2 2026 revenue and EPS?
Orthofix Medical Inc. reported revenue of $210.9M and eps of $-0.39 for Q2 2026.
Did Orthofix Medical Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $209.3M by $1.7M. EPS beat the consensus estimate of $-0.41 by $0.02.
How did Orthofix Medical Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.8% from $203.1M a year earlier.
Where can I find Orthofix Medical Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-333817) and the 10-Q periodic report (0001193125-26-333822) directly on SEC EDGAR. The filing index links above go to sec.gov.